ERAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.995190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.122400E-02
Normal-vs-Stage2
2.760000E-01
Normal-vs-Stage3
6.256100E-03
Normal-vs-Stage4
2.608000E-01
Stage1-vs-Stage2
4.737200E-01
Stage1-vs-Stage3
1.908450E-01
Stage1-vs-Stage4
6.752600E-01
Stage2-vs-Stage3
9.775700E-02
Stage2-vs-Stage4
8.683200E-01
Stage3-vs-Stage4
1.548790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.493580E-01
Normal-vs-AfricanAmerican
9.550800E-01
Normal-vs-Asian
3.344200E-01
Caucasian-vs-AfricanAmerican
3.112200E-01
Caucasian-vs-Asian
6.159000E-01
AfricanAmerican-vs-Asian
3.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.006200E-01
Normal-vs-Female
2.120000E-01
Male-vs-Female
9.850200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.873700E-02
Normal-vs-Age(41-60Yrs)
3.789800E-01
Normal-vs-Age(61-80Yrs)
1.774570E-01
Normal-vs-Age(81-100Yrs)
2.430500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.894630E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.241600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.053400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.323800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.435900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.705800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.150000E-02
Normal-vs-Daily Drinker
6.386400E-02
Normal-vs-Weekly Drinker
2.283600E-01
Normal-vs-Occasional Drinker
9.186500E-02
Normal-vs-Social Drinker
6.572400E-01
Non Drinker-vs-Daily Drinker
9.549800E-01
Non Drinker-vs-Weekly Drinker
8.295800E-01
Non Drinker-vs-Occasional Drinker
2.601600E-01
Non Drinker-vs-Social Drinker
8.882600E-03
Daily Drinker-vs-Weekly Drinker
7.969200E-01
Daily Drinker-vs-Occasional Drinker
3.087800E-01
Daily Drinker-vs-Social Drinker
2.162300E-02
Weekly Drinker-vs-Occasional Drinker
6.457400E-01
Weekly Drinker-vs-Social Drinker
1.259370E-01
Occasional Drinker-vs-Social Drinker
1.131830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.283400E-01
Normal-vs-Grade 2
9.066200E-02
Normal-vs-Grade 3
4.386100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.392400E-01
Grade 1-vs-Grade 3
9.556000E-02
Grade 1-vs-Grade 4
2.283400E-01
Grade 2-vs-Grade 3
4.466800E-01
Grade 2-vs-Grade 4
9.066200E-02
Grade 3-vs-Grade 4
4.386100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.106970E-01
Normal-vs-NonDiabetic
1.621420E-01
Diabetic-vs-NonDiabetic
4.580400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.324800E-01
Normal-vs-NoPancreatitis
1.593580E-01
Pancreatitis-vs-NoPancreatitis
9.150600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.479430E-01
Normal-vs-N1
2.414200E-01
N0-vs-N1
3.929600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.986980E-01
Normal-vs-TP53-NonMutant
2.603200E-01
TP53-Mutant-vs-TP53-NonMutant
9.498800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
